HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors
- 26 March 2010
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 95 (3) , 365-370
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Head and neck cancerThe Lancet, 2008
- Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): An UpdateInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Chemoradiotherapy for Locally Advanced Head and Neck CancerJournal of Clinical Oncology, 2007
- Individual patients' data meta-analyses in head and neck cancerCurrent Opinion in Oncology, 2007
- The chemoradiation paradigm in head and neck cancerNature Clinical Practice Oncology, 2007
- Racial Disparities in Patients With Head and Neck Squamous Cell CarcinomaThe Laryngoscope, 2006
- A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neckBMC Cancer, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Tumor Volume Predicts Outcome for Advanced Head and Neck Cancer Treated With Targeted ChemoradiotherapyThe Laryngoscope, 2002
- Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysisHead & Neck, 2001